Katherine D Wysham1, Jane Shofer2, Gabriella Lui3, Laura Trupin4, James S Andrews3, Dennis M Black5, Jonathan Graf4, Dolores M Shoback6, Patricia P Katz4. 1. Arthritis Section, VA Puget Sound Health Care System, Seattle, WA, USA; Division of Rheumatology, Department of Medicine, University of Washington Department of Medicine, Seattle, WA, USA. Electronic address: kwysham@uw.edu. 2. Arthritis Section, VA Puget Sound Health Care System, Seattle, WA, USA; Division of Rheumatology, Department of Medicine, University of Washington Department of Medicine, Seattle, WA, USA. 3. Division of Rheumatology, Department of Medicine, University of Washington Department of Medicine, Seattle, WA, USA. 4. Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. 5. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA. 6. Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; Endocrinology Section, San Francisco VA Medical Center, San Francisco, CA, USA.
Abstract
OBJECTIVE: Prior studies have found conflicting results when evaluating the association between rheumatoid arthritis (RA) disease activity and bone mineral density (BMD). Whether or not cumulative RA disease activity is associated with BMD remains unanswered. METHODS: Data were from the University of California San Francisco RA Cohort from years 2006-2018. Those with BMD measures and at least two study visits prior to BMD measure were included in the study. The association between low cumulative disease activity, as measured by DAS28ESR, with the primary outcome of femoral neck BMD was assessed using multivariable linear regression. Sensitivity analyses were performed substituting CDAI for the disease activity measure as well as total hip and lumbar spine BMD as outcomes. RESULTS: 161 participants with RA were studied. The cohort was 62.4 ± 10.2 years old and 88% female. Hispanic/Latino (N = 73, 45%) and Asian (N = 59, 37%) were the most common racial/ethnic groups in our cohort. Mean RA duration was 10.5 ± 7.3 years and 83% were ACPA positive. Low disease activity was independently associated with higher femoral neck BMD compared to the moderate/high disease activity group (β= 0.071 [95%CI: 0.021 to 0.122], p = 0.020). The relationship between low cumulative disease activity was similar when CDAI and other BMD sites were substituted in the multivariable models. CONCLUSION: Low cumulative disease activity as measured by DAS28ESR was associated with higher femoral neck BMD, independent of traditional osteoporosis risk factors (e.g., age, sex, BMI) in a unique RA cohort. Results were similar when evaluating cumulative low CDAI and other BMD sites. Published by Elsevier Inc.
OBJECTIVE: Prior studies have found conflicting results when evaluating the association between rheumatoid arthritis (RA) disease activity and bone mineral density (BMD). Whether or not cumulative RA disease activity is associated with BMD remains unanswered. METHODS: Data were from the University of California San Francisco RA Cohort from years 2006-2018. Those with BMD measures and at least two study visits prior to BMD measure were included in the study. The association between low cumulative disease activity, as measured by DAS28ESR, with the primary outcome of femoral neck BMD was assessed using multivariable linear regression. Sensitivity analyses were performed substituting CDAI for the disease activity measure as well as total hip and lumbar spine BMD as outcomes. RESULTS: 161 participants with RA were studied. The cohort was 62.4 ± 10.2 years old and 88% female. Hispanic/Latino (N = 73, 45%) and Asian (N = 59, 37%) were the most common racial/ethnic groups in our cohort. Mean RA duration was 10.5 ± 7.3 years and 83% were ACPA positive. Low disease activity was independently associated with higher femoral neck BMD compared to the moderate/high disease activity group (β= 0.071 [95%CI: 0.021 to 0.122], p = 0.020). The relationship between low cumulative disease activity was similar when CDAI and other BMD sites were substituted in the multivariable models. CONCLUSION: Low cumulative disease activity as measured by DAS28ESR was associated with higher femoral neck BMD, independent of traditional osteoporosis risk factors (e.g., age, sex, BMI) in a unique RA cohort. Results were similar when evaluating cumulative low CDAI and other BMD sites. Published by Elsevier Inc.
Authors: Katherine D Wysham; Dolores M Shoback; John B Imboden; Patricia P Katz Journal: Arthritis Care Res (Hoboken) Date: 2018-05-09 Impact factor: 4.794
Authors: M C Lodder; Z de Jong; P J Kostense; E T H Molenaar; K Staal; A E Voskuyl; J M W Hazes; B A C Dijkmans; W F Lems Journal: Ann Rheum Dis Date: 2004-12 Impact factor: 19.103
Authors: Barbara Hauser; Philip L Riches; James F Wilson; Annamarie E Horne; Stuart H Ralston Journal: Rheumatology (Oxford) Date: 2014-04-24 Impact factor: 7.580
Authors: M C van der Goes; J W G Jacobs; M S Jurgens; M F Bakker; M J van der Veen; J H van der Werf; P M J Welsing; J W J Bijlsma Journal: Osteoporos Int Date: 2012-08-02 Impact factor: 4.507